Insemination Clinical Trial
— UGAINCT number | NCT00809952 |
Other study ID # | HUMREP-08-0656 |
Secondary ID | |
Status | Completed |
Phase | Phase 4 |
First received | December 15, 2008 |
Last updated | December 15, 2008 |
Verified date | December 2008 |
Source | Hospital de Cruces |
Contact | n/a |
Is FDA regulated | No |
Health authority | Spain: Ministry of Health |
Study type | Observational |
The purpose of this study is to ascertain whether using ultrasound guidance during intrauterine insemination (IUI) could increase pregnancy rates.
Status | Completed |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - The woman's inclusion criteria in our IUI program were at least one patent tube, normal cavity, basal FSH < 10 mU/mL and age under 40 years. - IUI with husband's sperm (IUI-H) was indicated when, after sperm preparation, at least 5 million motile spermatozoa were recovered; this was performed in 58 cases (79.45%). - In the remaining 15 cases (20.55%), IUI was performed with donor sperm (IUI-D) either because of azoospermia (n=6) failure to recover spermatozoa during testicular biopsy (n=5) or in women without a male partner (n=4). Exclusion Criteria: - Previous infertility treatments had been carried out. |
N/A
Country | Name | City | State |
---|---|---|---|
Spain | Human Reproduction Unit | Cruces-Baracaldo | Basque Country |
Lead Sponsor | Collaborator |
---|---|
Hospital de Cruces |
Spain,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05999591 -
Total Motile Sperm Count and Pregnancy Rate From Intrauterine Insemination
|
||
Recruiting |
NCT02315040 -
EVIE-Study: Slow Release Insemination Versus Standard Intrauterine Insemination Study
|
Phase 3 | |
Recruiting |
NCT03435809 -
Pozzi Forceps in Intrauterine Insemination
|
N/A | |
Completed |
NCT01999959 -
Effect of Pertubation on Pregnancy Rates Before Intrauterine Insemination Treatment
|
Phase 2 |